GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 27 filers reported holding GEMPHIRE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $10,000 | 0.0% | 12,910 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $10,000 | -33.3% | 12,910 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $15,000 | +50.0% | 12,910 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -63.0% | 12,910 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $27,000 | -72.4% | 12,910 | 0.0% | 0.00% | -71.4% |
| Q2 2018 | $98,000 | +16.7% | 12,910 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $84,000 | -18.4% | 12,910 | 0.0% | 0.01% | -22.2% |
| Q4 2017 | $103,000 | -16.3% | 12,910 | 0.0% | 0.01% | -35.7% |
| Q3 2017 | $123,000 | -11.5% | 12,910 | +18.8% | 0.01% | -22.2% |
| Q2 2017 | $139,000 | – | 10,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exchange Capital Management, Inc. | 758,623 | $7,966,000 | 2.88% |
| Cormorant Asset Management, LP | 952,798 | $10,004,000 | 1.45% |
| DAFNA Capital Management LLC | 52,797 | $554,000 | 0.47% |
| HIGHLAND CAPITAL MANAGEMENT LP | 316,789 | $3,326,000 | 0.17% |
| Cambridge Investment Research Advisors, Inc. | 150,564 | $1,581,000 | 0.03% |
| NORRIS PERNE & FRENCH LLP/MI | 10,463 | $110,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 634,246 | $6,660,000 | 0.02% |
| SEGALL BRYANT & HAMILL, LLC | 11,000 | $116,000 | 0.00% |
| Acrospire Investment Management LLC | 400 | $4,000 | 0.00% |
| Advisor Group, Inc. | 5,112 | $54,000 | 0.00% |